ATOSSA THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Atossa Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2024.
  • Atossa Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 126M shares, a 0.4% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 126M +497K +0.4% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 126M -748K -0.59% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 126M -1.12M -0.88% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 126M -823K -0.65% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 125M -1.32M -1.04% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 127M -119K -0.09% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 127M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 127M +110 0% Dec 31, 2022 10-K 2024-04-01
Q3 2022 127M +459 0% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 127M +699K +0.56% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 127M +5.8M +4.8% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 127M +79.1M +166% Dec 31, 2021 10-K 2023-03-22
Q3 2021 127M +116M +1110% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 126M +117M +1253% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 121M +112M +1223% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 47.6M +38.4M +421% Dec 31, 2020 10-K 2022-02-28
Q3 2020 10.5M +1.33M +14.6% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 9.3M +174K +1.91% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 9.13M +8.81K +0.1% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 9.13M +3.28M +56.2% Dec 31, 2019 10-K 2021-03-31
Q3 2019 9.13M +3.61M +65.3% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 9.13M +4.26M +87.3% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 9.12M +6.47M +244% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 5.85M +3.19M +120% Dec 31, 2018 10-K 2020-03-26
Q3 2018 5.52M -8.5M -60.6% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 4.87M -5.16M -51.4% Jun 30, 2018 10-Q/A 2018-11-13
Q1 2018 2.65M -1.13M -30% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 2.65M -1.13M -30% Dec 31, 2017 10-K 2019-03-28
Q3 2017 14M +10.2M +270% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 10M -29.5M -74.6% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 3.79M -35M -90.2% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 3.79M -28.9M -88.4% Dec 31, 2016 10-K 2018-03-08
Q3 2016 3.79M -26.7M -87.6% Sep 30, 2016 10-Q/A 2017-03-21
Q2 2016 39.6M +10.5M +36.2% Jun 30, 2016 10-Q/A 2017-03-21
Q1 2016 38.8M +11.6M +42.6% Mar 31, 2016 10-Q/A 2017-03-21
Q4 2015 32.7M +8.09M +32.9% Dec 31, 2015 10-Q/A 2017-03-21
Q3 2015 30.4M +5.88M +23.9% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 29M +4.6M +18.8% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 27.2M +2.79M +11.4% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 24.6M +5.99M +32.2% Dec 31, 2014 10-K 2016-03-30
Q3 2014 24.6M +7.12M +40.8% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 24.4M +9.11M +59.4% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 24.4M +9.92M +68.4% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 18.6M +5.65M +43.8% Dec 31, 2013 10-K 2015-03-30
Q3 2013 17.4M +5.33M +43.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 15.3M Jun 30, 2013 10-Q 2013-08-14
Q1 2013 14.5M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 12.9M +1.66M +14.8% Dec 31, 2012 10-K 2014-03-27
Q3 2012 12.1M Sep 30, 2012 10-Q/A 2013-01-22
Q4 2011 11.3M Dec 31, 2011 10-K 2013-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.